Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter Maes
Peter Maes
Celgene
Apremilast
Phosphodiesterase 4 Inhibitor
Medicine
Internal medicine
Diabetes mellitus
2
Papers
40
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and Safety of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2 Open-Label Study
2019
Journal of The American Academy of Dermatology
Amy S. Paller
Ying Hong
Emily M. Becker
Raúl de Lucas
Maria Paris
Wendy Zhang
Zuoshun Zhang
Claire Barcellona
Peter Maes
Loretta Fiorillo
Show All
Source
Cite
Save
Citations (15)
Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.
2015
Arthritis & Rheumatism
Mark C. Genovese
Katerina Jarosova
Dorota Cieślak
Jeffrey Alper
Alan J. Kivitz
Douglas Hough
Peter Maes
Lilia Pineda
Mindy Chen
Farrukh Zaidi
Show All
Source
Cite
Save
Citations (25)
1